Original news and analysis on international IP policy
A civil society coalition is after one of European Monsanto's patents, accusing the giant seed corporation of biopiracy. The patent granted in February was challenged by the No Patents on Seeds coalition, which filed an opposition a few days ago.
For the first time, the European Advocate-General has suggested on the grounds of European competition law the context for negotiations of fair, reasonable and non-discriminatory (FRAND) terms, and has set criteria for the enforcement of injunctions and other remedies in actions involving infringement of standard-essential patents (SEPs). The Court of Justice of the European Union (CJEU) decision is still pending.
The Medicines Patent Pool (MPP) has announced a licence agreement with pharmaceutical manufacturer AbbVie to allow the production of cheaper, more accessible paediatric versions of two HIV medicines.
China has set up an administrative office called the Shanghai City Pudong New Area Intellectual Property Office, integrating patent, trademark and copyright administration in the Pudong New Area in Shanghai city.
The fate of a potential treaty meant to harmonise international industrial design registration formalities took another turn this week, as African countries asked that the treaty include a safeguard against misuse and misappropriation of their traditional designs, which was seen by developed countries as a manoeuvre to delay the process.
Alberto Bichi is secretary-general of the Federation of the European Sporting Goods Industry (FESI), based in Brussels. In an interview with Intellectual Property Watch’s Catherine Saez, he describes FESI's mission, the views of the industry on the importance of intellectual property protection, and the growing issue of counterfeiting. He also talked about the industry's concern over the current European Union customs regulation on goods in transit, which, according to him is negatively impacting the sector.
The highly esteemed Center for International Intellectual Property Studies (CEIPI) in Strasbourg will mark its 50th anniversary this week with a conference featuring the top names in the European IP community. Below is the press release announcing the event: Conference…
On the first day of the World Intellectual Property Organization committee on trademarks and designs the focus was on a proposal from the African Group to include a disclosure requirement in international industrial design applications. Up to now the stumbling block preventing delegates from moving to a high-level treaty negotiation has been technical assistance. This additional parameter might come in the way of swift agreement.
"Nearly one-third of all Silicon Valley start-ups have an Indian-American co-founder," United States Trade Representative Michael Froman said in remarks on India today. The country of India is also innovating, but it must do more to have and enforce a world-class intellectual property rights regime, he said.
By Pamela Passman Economic globalization and digitization of information have revolutionized business and allowed for efficiency that was unimaginable a few decades ago. The ability to share information remotely means companies can coordinate with partners remotely, integrate suppliers, track shipments…
The 2014 edition of an independent ranking of leading pharmaceutical companies' efforts to help developing countries released today found new initiatives undertaken in the past two years. But it said corruption and insufficient disclosure of existing patents continue to plague the industry.
Public health activists and others have been watching closely in recent months as United States government and industry officials meet steadily and intensively with Indian counterparts to press change in that country's intellectual property policy toward greater protection and recognition of western IP rights. A particular area of concern has been in pharmaceuticals, as India is said to be the world's top supplier of affordable generic versions of drugs under patent that otherwise would be out of reach for millions of poor patients. Several activists have raised alarm over a meeting this week of US IP industry representatives with top judges in India.